[{"data":1,"prerenderedAt":174},["ShallowReactive",2],{"drug-levonorgestrel-ethinylestradiol":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":20,"formulations":28,"regimens":52,"contraindications":76,"warnings":95,"renal":96,"monitoring":97,"interactions":98,"review":99,"examples":102,"atc":108,"iran":110,"links":122,"populations":143,"usApproval":169},"levonorgestrel-ethinylestradiol",1,{"fa":7,"en":8},"قرص ضد بارداری LD (لوونورژسترل + اتینیل استرادیول)","Levonorgestrel\u002Fethinyl estradiol (LD pill)","genitourinary-sex-hormones",{"fa":11,"en":12},"ضدبارداری ترکیبی خوراکی","Combined oral contraceptive",[14,17],{"name":15,"market":16},"Levora","US",{"name":18,"market":19},"Microgynon","GB",[21,22,23,24,25,26,27],"LD","ال دی","قرص ال دی","OCP","microgynon","میکروژینون","قرص ضد بارداری",[29],{"id":30,"form":31,"route":32,"label":33,"concentration":34,"components":37,"markets":47,"refs":48},"tab","tablet","oral","Levonorgestrel 0.15 mg + ethinyl estradiol 0.03 mg",{"amount":35,"unit":36,"perUnit":31},0.15,"mg",{"levonorgestrel":38,"ethinylestradiol":42},{"name":39,"amount":35,"unit":36},{"fa":40,"en":41},"لوونورژسترل","Levonorgestrel",{"name":43,"amount":46,"unit":36},{"fa":44,"en":45},"اتینیل استرادیول","Ethinyl estradiol",0.03,[16],[49],{"source":50,"section":51},"fda-levora","Description",[53],{"id":54,"disease":55,"label":56,"population":59,"type":63,"unit":36,"dose":64,"refs":65,"doseComponent":68,"notes":69},"coc","contraception",{"fa":57,"en":58},"پیشگیری از بارداری — یک قرص روزانه در ساعت ثابت","Contraception — one tablet daily at the same time",{"minAge":60},{"value":61,"unit":62},12,"year","fixed",{"perDose":35,"dosesPerDay":5},[66],{"source":50,"section":67},"Dosage and Administration","levonorgestrel",[70],{"text":71,"refs":74},{"fa":72,"en":73},"به ترتیب بسته (۲۱ قرص فعال + ۷ قرص بی‌اثر). قرص فراموش‌شده هر چه زودتر.","In blister order (21 active + 7 inert). Take a missed pill as soon as possible.",[75],{"source":50,"section":67},[77,86],{"id":78,"severity":79,"text":80,"refs":83},"smoke","warn",{"fa":81,"en":82},"هشدار جعبه‌ای: در زنان بالای ۳۵ سال سیگاری منع مصرف (حوادث قلبی‌عروقی).","Boxed warning: contraindicated in women over 35 who smoke (cardiovascular events).",[84],{"source":50,"section":85},"Boxed Warning",{"id":87,"severity":88,"text":89,"refs":92},"ci","block",{"fa":90,"en":91},"سابقه ترومبوز وریدی یا شریانی، سرطان پستان، بیماری کبد، بارداری و سایر موارد بخش منع مصرف.","History of venous or arterial thrombosis, breast cancer, liver disease, pregnancy and others in Contraindications.",[93],{"source":50,"section":94},"Contraindications",[],[],[],[],{"status":100,"reviewer":101,"date":101},"unverified",null,[103],{"regimen":54,"formulation":30,"input":104,"expect":107},{"ageYears":105,"weightKg":106},25,60,{"perDose":35,"tabletsPerDoseRounded":5},[109],"G03AA07",{"status":111,"forms":112,"refs":117},"registered",[113],{"code":114,"en":115,"fa":116},"00357","CONTRACEPTIVE LD X21 TAB","قرص ضدبارداری لد X ۲۱",[118],{"source":119,"section":120,"url":121},"darooyab-generic","G-4516\u002FContraceptive-LD","https:\u002F\u002Fwww.darooyab.ir\u002FG-4516\u002FContraceptive-LD",[123,127,131,134,137,140],{"kind":124,"url":125,"label":126},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=073594","ANDA073594",{"kind":128,"url":129,"label":130},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=31679b9f-58c9-4bf1-8c2c-f5a216ff4cd3","FDA Levora",{"kind":132,"url":133,"label":41},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa610021.html",{"kind":132,"url":135,"label":136},"https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa613047.html","Levonorgestrel Intrauterine System",{"kind":138,"url":139,"label":109},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=G03AA07",{"kind":141,"url":121,"label":142},"darooyab","Contraceptive-LD",{"pregnancy":144,"pediatric":153,"geriatric":161},{"level":145,"text":146,"quote":149,"refs":150},"caution",{"fa":147,"en":148},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Risk Summary Discontinue LEVORA 0.15\u002F30-28 if pregnancy occurs because there is no reason to use COCs in pregnancy.",[151],{"source":50,"section":152},"Precautions\u002FWarnings – Pregnancy",{"level":145,"text":154,"quote":157,"refs":158},{"fa":155,"en":156},"برچسب برای کودکان شرط، محدودیت سنی یا نکته دارد؛ جمله برچسب در زیر آمده است.","The label has conditions, age limits or notes for children; the label sentence is quoted below.","Safety and efficacy of LEVORA 0.15\u002F30-28 have been established in females of reproductive potential.",[159],{"source":50,"section":160},"Precautions\u002FWarnings – Pediatric Use",{"level":145,"text":162,"quote":165,"refs":166},{"fa":163,"en":164},"برچسب: در سالمندان با احتیاط و معمولاً از دوز پایین شروع شود.","Label: use with caution in older adults, usually starting at the low end of the dose range.","LEVORA 0.15\u002F30-28 has not been studied in postmenopausal women and is not indicated in this population. 10.",[167],{"source":50,"section":168},"Precautions\u002FWarnings – Geriatric Use",{"kind":170,"refs":171,"id":126},"ANDA",[172],{"source":50,"section":173},"SPL approval \u002F marketing category",1792444704553]